In COVID-19 clinical update #115, Dr. Griffin reviews cross-variant immunity without vaccination, EUA for boosters in 5-11 year olds, B.1.1.529 attack rate, scent dogs, Omicron and pets, Paxlovid, Veklury, Fluvoxamine, antigen positivity after isolation, inflammasome activation and severe disease, and…
In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from…
In COVID-19 clinical update #98, Daniel Griffin reviews COVID-19 in South Africa, recognition of Omicron by ancestral T cells, booster effectiveness against disease, infection and vaccination in pregnant women, early Remdesivir to prevent progression to severe disease, management of hospitalized…
In COVID-19 clinical update #97, Daniel Griffin covers immunity after infection recognized by CDC, outcomes before and after Omicron, infectious viral load in Delta vs Omicron, PCR vs rapid antigen tests, booster interval shortened to 5 months, risk factors for…
COVID 19 2021 Update: Supplements for COVID, Ivermectin, Leronlimab, RLF 100, Monoclonal Antibodies In this video, I will be discussing The COVID 19 Medicines, which many have never heard of But NEED to KNOW. Vitamin D, Vitamin C, Zinc, Ivermectin,…
ST. LOUIS — Over a week after President Donald Trump walked out of the hospital following his COVID-19 diagnosis, his drug cocktail Regeneron still generates buzz. Drugmakers want the FDA to grant emergency-use authorization for the COVID-19 treatment, as medical…
